Back to search
Dementia Alzheimer Type
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Dementia Alzheimer Type trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Dementia Alzheimer Type trials you may qualify forThe goal of this placebo-controlled double-blind Phase 2 clinical trial is to test in people with early Alzheimer's Disease. The main questions it aims to answ…
This current translational project, funded by NIH, aims to better understand the impact of various signal modification strategies for older adults with Alzheime…
The primary objective of this study is to evaluate the efficacy of DMTS on frequency and severity of agitation associated with dementia of the Alzheimer's type,…
An open-label, exploratory, phase II, proof-of concept, clinical study to assess the safety and tolerability of EI-1071 and the effects of EI-1071 on neuroinfla…
Using a new formulation of rifaximin, a non-absorbable antibiotic, to test if it can affect microbes in the gut of patients with dementia favorably.
The goal of this observational study is to learn how daily emotional stress affects cognitive function and inflammation in community-dwelling older adults aged…
This is a randomized, double-blind, sham-controlled pivotal study of sensory stimulation in subjects with mild to moderate AD. Up to approximately 670 subjects…
The goal of this study is to characterize biophysiolgoical signals as a comprehensive profile of the nervous systems in order to understand interactions between…
This is a one-arm pilot study testing the feasibility and acceptability of a decision aid about safe firearm storage.